Forbes August 31, 2025
In 2023, Multiply Labs partnered with Legend Biotech to automate cell therapy production. In August 2025, the San Francisco startup became Universal Robots’ first official partner in the cell and gene therapy sector to advance robotic clusters that cut costs and boost manufacturing scale.
Cell and gene therapies are among the most advanced cancer treatments, but manufacturing them has been slow, costly and challenging to scale. Each dose is customized from a patient’s own cells and can cost between $300,000 and two million. The process requires hundreds of delicate manual steps, and any contamination renders a dose unusable.
“Even the best technicians can only work so fast, and human hands inevitably introduce variability and contamination,” said Fred Parietti, CEO of...
Today's Sponsors
Today's Sponsor